Ewa A Jankowska1, Elzbieta Kalicinska2, Marcin Drozd3, Beata Kurian4, Waldemar Banasiak5, Piotr Ponikowski2. 1. Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland; Cardiology Department, Centre for Heart Diseases, Military Hospital, Wroclaw, Poland. Electronic address: ewa.jankowska@umed.wroc.pl. 2. Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland; Cardiology Department, Centre for Heart Diseases, Military Hospital, Wroclaw, Poland. 3. Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland. 4. Merck, Warsaw, Poland. 5. Cardiology Department, Centre for Heart Diseases, Military Hospital, Wroclaw, Poland.
Abstract
OBJECTIVE: We sought to determine and compare clinical profile and management of outpatients with heart failure with reduced ejection fraction (HFREF) treated by cardiologists and general practitioners (GPs) in Poland. METHODS: All the 790 randomly selected cardiologists and GPs in the DATA-HELP registry, which included 5563 patients, filled out questionnaires about 10 consecutive outpatients with HFREF. RESULTS:Outpatients managed by GPs were older (69±10 vs 66±12 years), and the prevalence of men was less marked (58% vs 67%). They also had higher left ventricular ejection fraction (38±6% vs 35±8%) and had more pulmonary congestion (63% vs 49%) and peripheral oedema (66% vs 51%), compared with those treated by cardiologists (all p<0.001). Hypertension (74% vs 66%), previous stroke and/or transient ischaemic attack (21% vs 16%), diabetes (40% vs 30%), and chronic obstructive pulmonary disease (14% vs 11%) were more common in outpatients of GPs (all p<0.001). GPs were less likely to prescribe β-blocker (95% vs 97%, p<0.01), mineralocorticoid receptor antagonist (MRA) (56% vs 64%, p<0.001), and loop diuretic (61% vs 64%, p<0.05) or use PCI (33% vs 44%, p<0.001), CABG (11% vs 16%, p<0.001), ICD (4% vs 10%, p<0.001), or CRT (1% vs 5%, p<0.001). Prescription of renin-angiotensin system inhibitors (94% vs 94%, p>0.2) and digoxin (20% vs 21%, p>0.2) by GPs and cardiologists was similar. CONCLUSION: In contemporary Poland, most outpatients with HFREF receive drugs that improve survival and undergo revascularisation procedures, although devices are rare, but the clinical profiles and management of those treated by GPs and cardiologists differ. Outpatients treated by GPs are older and have more co-morbidities. Outpatients treated by cardiologists more commonly receive β-blocker, MRA, ICD, and CRT, and undergo coronary revascularisations.
RCT Entities:
OBJECTIVE: We sought to determine and compare clinical profile and management of outpatients with heart failure with reduced ejection fraction (HFREF) treated by cardiologists and general practitioners (GPs) in Poland. METHODS: All the 790 randomly selected cardiologists and GPs in the DATA-HELP registry, which included 5563 patients, filled out questionnaires about 10 consecutive outpatients with HFREF. RESULTS: Outpatients managed by GPs were older (69±10 vs 66±12 years), and the prevalence of men was less marked (58% vs 67%). They also had higher left ventricular ejection fraction (38±6% vs 35±8%) and had more pulmonary congestion (63% vs 49%) and peripheral oedema (66% vs 51%), compared with those treated by cardiologists (all p<0.001). Hypertension (74% vs 66%), previous stroke and/or transient ischaemic attack (21% vs 16%), diabetes (40% vs 30%), and chronic obstructive pulmonary disease (14% vs 11%) were more common in outpatients of GPs (all p<0.001). GPs were less likely to prescribe β-blocker (95% vs 97%, p<0.01), mineralocorticoid receptor antagonist (MRA) (56% vs 64%, p<0.001), and loop diuretic (61% vs 64%, p<0.05) or use PCI (33% vs 44%, p<0.001), CABG (11% vs 16%, p<0.001), ICD (4% vs 10%, p<0.001), or CRT (1% vs 5%, p<0.001). Prescription of renin-angiotensin system inhibitors (94% vs 94%, p>0.2) and digoxin (20% vs 21%, p>0.2) by GPs and cardiologists was similar. CONCLUSION: In contemporary Poland, most outpatients with HFREF receive drugs that improve survival and undergo revascularisation procedures, although devices are rare, but the clinical profiles and management of those treated by GPs and cardiologists differ. Outpatients treated by GPs are older and have more co-morbidities. Outpatients treated by cardiologists more commonly receive β-blocker, MRA, ICD, and CRT, and undergo coronary revascularisations.
Authors: Uwe Zeymer; Andrew L Clark; Vivencio Barrios; Thibaud Damy; Jaroslaw Drożdż; Candida Fonseca; Lars H Lund; Gabriele Di Comite; Stephan Hupfer; Aldo P Maggioni Journal: ESC Heart Fail Date: 2020-02-06
Authors: Krzysztof Myrda; Piotr Rozentryt; Jacek T Niedziela; Aneta Ociessa; Maria Kasperova; Bartosz Hudzik; Jolanta U Nowak; Mariusz Gąsior Journal: Kardiochir Torakochirurgia Pol Date: 2015-09-28
Authors: Alice M Jackson; Pooja Dewan; Inder S Anand; Jan Bělohlávek; Olof Bengtsson; Rudolf A de Boer; Michael Böhm; David W Boulton; Vijay K Chopra; David L DeMets; Kieran F Docherty; Andrej Dukát; Peter J Greasley; Jonathan G Howlett; Silvio E Inzucchi; Tzvetana Katova; Lars Køber; Mikhail N Kosiborod; Anna Maria Langkilde; Daniel Lindholm; Charlotta E A Ljungman; Felipe A Martinez; Eileen O'Meara; Marc S Sabatine; Mikaela Sjöstrand; Scott D Solomon; Sergey Tereshchenko; Subodh Verma; Pardeep S Jhund; John J V McMurray Journal: Circulation Date: 2020-07-16 Impact factor: 29.690